Motivation to pursue anti-TNFα treatment in patients with Crohn's disease - the SPACE motivation study.

Date publication

juin 2020

Journal

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent

Tous les auteurs :
D'Amico F, Peyrin-Biroulet L, Vandromme L, Bouhnik Y, Faure P, Nahon S, Hagege H, Hebuterne X, Benkhalifa S, Nachury M

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/32532602

Résumé

Crohn's disease (CD) is a chronic disorder requiring long-term treatment. However, up to 20% of patients interrupt temporarily or permanently anti-TNFα. Primary aim was to identify internal and external factors influencing patient's motivation to pursue anti-TNFα in active CD.

Mots clés

Anti-tumor necrosis factor α, Crohn's disease, Motivation, Satisfaction of patients with Crohn's disease questionnaire (SPACE-Q), Treatment adherence

Référence

Dig Liver Dis. 2020 Jun 9;: